BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15192084)

  • 1. Disposition kinetics of propranolol isomers in the perfused rat liver.
    Hung DY; Siebert GA; Chang P; Anissimov YG; Roberts MS
    J Pharmacol Exp Ther; 2004 Nov; 311(2):822-9. PubMed ID: 15192084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ion-trapping, microsomal binding, and unbound drug distribution in the hepatic retention of basic drugs.
    Siebert GA; Hung DY; Chang P; Roberts MS
    J Pharmacol Exp Ther; 2004 Jan; 308(1):228-35. PubMed ID: 14566005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic pharmacokinetics of propranolol in rats with adjuvant-induced systemic inflammation.
    Hung DY; Siebert GA; Chang P; Whitehouse MW; Fletcher L; Crawford DH; Roberts MS
    Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G343-51. PubMed ID: 16166348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide induced sinusoidal relaxation after a propranolol priming dose in the perfused rat liver reduces propranolol availability on subsequent dosing.
    Liu X; Zou Y; Khlentzos AM; Yang Y; Nikolovski J; Weiss M; Roberts MS
    Clin Exp Pharmacol Physiol; 2010 Oct; 37(10):1028-33. PubMed ID: 20659130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced extraction of I-propranolol by perfused rat liver in the presence of uremic blood.
    Terao N; Shen DD
    J Pharmacol Exp Ther; 1985 May; 233(2):277-84. PubMed ID: 3999018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonspecific binding to microsomes: impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol.
    Obach RS
    Drug Metab Dispos; 1997 Dec; 25(12):1359-69. PubMed ID: 9394025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clearance by the liver in cirrhosis. I. Relationship between propranolol metabolism in vitro and its extraction by the perfused liver in the rat.
    Fenyves D; GariƩpy L; Villeneuve JP
    Hepatology; 1993 Feb; 17(2):301-6. PubMed ID: 8428728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dl-propranolol on lidocaine disposition in the perfused rat liver.
    Vu VT; Chen CP
    Drug Metab Dispos; 1982; 10(4):350-5. PubMed ID: 6126333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired elimination of propranolol due to right heart failure: drug clearance in the isolated liver and its relationship to intrinsic metabolic capacity.
    Ng CY; Ghabrial H; Morgan DJ; Ching MS; Smallwood RA; Angus PW
    Drug Metab Dispos; 2000 Oct; 28(10):1217-21. PubMed ID: 10997943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrimination between the venous equilibrium and sinusoidal models of hepatic drug elimination in the isolated perfused rat liver by perturbation of propranolol protein binding.
    Jones DB; Morgan DJ; Mihaly GW; Webster LK; Smallwood RA
    J Pharmacol Exp Ther; 1984 May; 229(2):522-6. PubMed ID: 6716274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced hepatic clearance of propranolol induced by chronic carbon tetrachloride treatment in rats.
    Iwamoto K; Watanabe J; Araki K; Satoh M; Deguchi N
    J Pharmacol Exp Ther; 1985 Aug; 234(2):470-5. PubMed ID: 4020680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clearance by the liver in cirrhosis. III. Propranolol uptake by the isolated perfused human liver.
    Villeneuve JP; Dagenais M; Huet PM; Lapointe R; Roy A; Marleau D
    Can J Physiol Pharmacol; 1996 Dec; 74(12):1327-32. PubMed ID: 9047043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance.
    Rane A; Wilkinson GR; Shand DG
    J Pharmacol Exp Ther; 1977 Feb; 200(2):420-4. PubMed ID: 839445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-hepatic disposition relationships for cationic drugs in isolated perfused rat livers: transmembrane exchange and cytoplasmic binding process.
    Hung DY; Chang P; Weiss M; Roberts MS
    J Pharmacol Exp Ther; 2001 May; 297(2):780-9. PubMed ID: 11303070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of hepatic metabolism affecting pharmacokinetics of propranolol in humans.
    Kiriyama A; Honbo A; Iga K
    Int J Pharm; 2008 Feb; 349(1-2):53-60. PubMed ID: 17765415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carrier-mediated entry of 4-methylumbelliferyl sulfate: characterization by the multiple-indicator dilution technique in perfused rat liver.
    Chiba M; Schwab AJ; Goresky CA; Pang KS
    Hepatology; 1998 Jan; 27(1):134-46. PubMed ID: 9425929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hypoxia/reperfusion injury on drug disposition in the rat isolated perfused liver.
    Arab HA; Cheung K; Hickman PE; Potter JM; Kadkhodaee M; Roberts MS
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):332-8. PubMed ID: 17324146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal hepatic propranolol metabolism. Studies in the isolated perfused fetal sheep liver.
    Ring JA; Ghabrial H; Ching MS; Shulkes A; Smallwood RA; Morgan DJ
    Drug Metab Dispos; 1995 Feb; 23(2):190-6. PubMed ID: 7736910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiologically based pharmacokinetic modeling of FTY720 (2-amino-2[2-(-4-octylphenyl)ethyl]propane-1,3-diol hydrochloride) in rats after oral and intravenous doses.
    Meno-Tetang GM; Li H; Mis S; Pyszczynski N; Heining P; Lowe P; Jusko WJ
    Drug Metab Dispos; 2006 Sep; 34(9):1480-7. PubMed ID: 16751263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of route of input on the hepatic disposition of diazepam.
    Sahin S; Rowland M
    J Pharmacol Exp Ther; 2000 Nov; 295(2):836-43. PubMed ID: 11046126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.